Epidemiological and genetic features of amyotrophic lateral sclerosis in Latin America and the Caribbean: a systematic review

References

• Marin B, Boumédiene F, Logroscino G, Couratier P, Babron M-C, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
   PubMed Web of Science ®Google Scholar
• Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68:1002–7.
   PubMed Web of Science ®Google Scholar
• Marin B, Logroscino G, Boumédiene F, Labrunie A, Couratier P, Babron M-C, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31:229–45.
   PubMed Web of Science ®Google Scholar
• Homburger JR, Moreno-Estrada A, Gignoux CR, Nelson D, Sanchez E, Ortiz-Tello P, et al. Genomic insights into the ancestry and demographic history of South America. PLOS Genet. 2015;11:e1005602.
   PubMed Web of Science ®Google Scholar
• Olivares L, Estéban ES, Alter M. Mexican “resistance” to amyotrophic lateral sclerosis. Arch Neurol. 1972;27:397–402.
   PubMedGoogle Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Luna J, Logroscino G, Couratier P, Marin B. Current issues in ALS epidemiology: variation of ALS occurrence between populations and physical activity as a risk factor. Rev Neurol. 2017;173:244–53.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLOS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• UNSD — Methodology [Internet]. Available at: https://unstats.un.org/unsd/methodology/m49/. Accessed May 4, 2020.
   Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016; 5:210.
   PubMed Web of Science ®Google Scholar
• Rodríguez- Paniagua P, Salas- Herrera I, Cartín- Brenes M. Incidencia de esclerosis lateral amiotrófica en Costa Rica. Acta Médica Costarricense. 2007;49:33–7.
   Google Scholar
• Bucheli M, Andino A, Montalvo M, Cruz J, Atassi N, Berry J, et al. Amyotrophic lateral sclerosis: analysis of ALS cases in a predominantly admixed population of Ecuador. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:106–13.
   PubMed Web of Science ®Google Scholar
• Lannuzel A, Mecharles S, Tressières B, Demoly A, Alhendi R, Hédreville-Tablon M-A, et al. Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: a new focus of ALS associated with Parkinsonism. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:216–23.
   PubMed Web of Science ®Google Scholar
• Vázquez MC, Ketzoián C, Legnani C, Rega I, Sánchez N, Perna A, et al. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. NED. 2008;30:105–11.
   Google Scholar
• Bettini M, Vicens J, Giunta DH, Rugiero M, Cristiano E. Incidence and prevalence of amyotrophic lateral sclerosis in an HMO of Buenos Aires, Argentina. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:598–603.
   PubMed Web of Science ®Google Scholar
• Zapata-Zapata CH, Franco Dáger E, Aguirre-Acevedo DC, de Carvalho M, Solano-Atehortúa J. Prevalence, incidence, and clinical-epidemiological characterization of amyotrophic lateral sclerosis in antioquia: Colombia. Neuroepidemiology. 2020;54:251–7.
   PubMed Web of Science ®Google Scholar
• Linden Junior E, Becker J, Schestatsky P, Rotta FT, Marrone CD, Gomes I. Prevalence of amyotrophic lateral sclerosis in the city of Porto Alegre, in Southern Brazil. Arq Neuropsiquiatr. 2013;71:959–62.
   PubMed Web of Science ®Google Scholar
• Matos S. E d, Conde MTRP, Fávero FM, Taniguchi M, Quadros AAJ, Fontes SV, et al. Mortality rates due to amyotrophic lateral sclerosis in São Paulo City from 2002 to 2006. Arq Neuropsiquiatr. 2011;69:861–6.
   PubMed Web of Science ®Google Scholar
• Moura MC, Casulari LA, Carvalho Garbi Novaes MR. Ethnic and demographic incidence of amyotrophic lateral sclerosis (ALS) in Brazil: a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:275–81.
   PubMed Web of Science ®Google Scholar
• Luna J, Preux P-M, Logroscino G, Erazo D, Del Brutto OH, Boumediene F, et al. Amyotrophic lateral sclerosis mortality rates among ethnic groups in a predominant admixed population in Latin America: a population-based study in Ecuador. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:1–9.
   Web of Science ®Google Scholar
• Chadi G, Maximino JR, Jorge F. d H, Borba F. d, Gilio JM, Callegaro D, et al. Genetic analysis of patients with familial and sporadic amyotrophic lateral sclerosis in a Brazilian Research Center. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:249–55.
   PubMed Web of Science ®Google Scholar
• Tavares de Andrade HM, Cintra VP, de Albuquerque M, Piccinin CC, Bonadia LC, Duarte Couteiro RE, et al. Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients. Neurobiol Aging. 2018;69:292.e15–e18.
   Web of Science ®Google Scholar
• Cintra VP, Bonadia LC, Andrade HMT, de Albuquerque M, Eusébio MF, de Oliveira DS, et al. The frequency of the C9orf72 expansion in a Brazilian population. Neurobiol Aging. 2018;66:179.e1–e4.
   PubMed Web of Science ®Google Scholar
• Itzcovich T, Xi Z, Martinetto H, Chrem-Méndez P, Russo MJ, de Ambrosi B, et al. Analysis of C9orf72 in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Argentina. Neurobiol Aging. 2016;40:192.e13–e15.
   Web of Science ®Google Scholar
• Ryan M, Zaldívar Vaillant T, McLaughlin RL, Doherty MA, Rooney J, Heverin M, et al. Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations. J Neurol Neurosurg Psychiatry. 2019;90:659–65.
   PubMed Web of Science ®Google Scholar
• Martínez HR, Molina-López JF, Cantú-Martínez L, González-Garza MT, Moreno-Cuevas JE, Couret-Alcaraz P, et al. Survival and clinical features in Hispanic amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler. 2011;12:199–205.
   PubMed Web of Science ®Google Scholar
• Gargiulo-Monachelli GM, Janota F, Bettini M, Shoesmith CL, Strong MJ, Sica REP. Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. Eur J Neurol. 2012;19:834–41.
   PubMed Web of Science ®Google Scholar
• Castro-Costa CM, Oriá RB, Vale OC, Arruda JA, Horta WG, D’Almeida JA, et al. Motor neuron diseases in the university hospital of Fortaleza (Northeastern Brazil): a clinico-demographic analysis of 87 cases. Arq Neuropsiquiatr. 2000;58:986–9.
   PubMed Web of Science ®Google Scholar
• Werneck LC, Bezerra R, Silveira Neto O. d, Scola RH. A clinical epidemiological study of 251 cases of amyotrophic lateral sclerosis in the south of Brazil. Arq Neuropsiquiatr. 2007;65:189–95.
   PubMed Web of Science ®Google Scholar
• Loureiro MPS, Gress CH, Thuler LCS, Alvarenga RMP, Lima JMB. Clinical aspects of amyotrophic lateral sclerosis in Rio de Janeiro/Brazil. J Neurol Sci. 2012;316:61–6.
   PubMed Web of Science ®Google Scholar
• Gil J, Vazquez MC, Ketzoian C, Perna A, Marin B, Preux PM, et al. Prognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population. Amyotroph Lateral Scler. 2009;10:355–60.
   PubMed Web of Science ®Google Scholar
• Moura MC, Novaes MRCG, Eduardo EJ, Zago YSSP, Freitas RDNB, Casulari LA. Prognostic factors in amyotrophic lateral sclerosis: a population-based study. PLOS One. 2015;10:e0141500.
   PubMed Web of Science ®Google Scholar
• Adry RAR da C, Lins CC, Kruschewsky R de A, Andrade Filho A. d S. Epidemiology of the amyotrophic lateral sclerosis Bahia: Brazil. Rev Chil Neurocir 2012;38:94–8.
   Google Scholar
• Marco R, Rivera-Reyes L. Motor neuron disease in Puerto Rico: a study of 76 cases. Bol Asoc Med P R. 1983;75:400–2.
   PubMedGoogle Scholar
• Abadía-Cubillo K, Díaz-Cascante C, Granados-Acuña C, Castro-Cordero J, Salas-Herrera I. Efectos del riluzol en la evolución clínica y sobrevida de los pacientes con esclerosis lateral amiotrófica en Costa Rica. Acta Médica Costarricense. 2015;57:172–8.
   Google Scholar
• Sánchez-Martínez CM, Choreño-Parra JA, Nuñez-Orozco L, Placencia-Álvarez N, Alvis-Castaño LM, Guadarrama-Ortiz P. A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis. BMC Neurol. 2019;19:261.
   PubMed Web of Science ®Google Scholar
• Prado L de GR, Bicalho ICS, Vidigal-Lopes M, Ferreira CJA, Mageste Barbosa LS, Gomez RS, et al. Amyotrophic lateral sclerosis in Brazil: case series and review of the Brazilian literature. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:282–8.
   PubMed Web of Science ®Google Scholar
• Dietrich-Neto F, Callegaro D, Dias-Tosta E, Silva HA, Ferraz ME, Lima JM, et al. Amyotrophic lateral sclerosis in Brazil: 1998 national survey. Arq Neuropsiquiatr. 2000;58:607–15
   PubMed Web of Science ®Google Scholar
• Torres Ramírez L, Guevara Silva EA, Mendoza Suárez G, Cosentino Esquerre C. Características clínicas de la Esclerosis Lateral Amiotrófica en el Instituto Nacional de Ciencias Neurológicas. Diagnóstico. 2009;48:7–12.
   Google Scholar
• Otero Siliceo E, Arriada-Mendicoa N, Balderrama J. Juvenile familial amyotrophic lateral sclerosis: four cases with long survival. Dev Med Child Neurol. 1998;40:425–8.
   PubMed Web of Science ®Google Scholar
• Deliz B, Ramos K, Pérez CM. Characterization of patients with amyotrophic lateral sclerosis attending the muscular dystrophy association–supported clinics in Puerto Rico. P R Health Sci J. 2018;37:5–11.
   PubMed Web of Science ®Google Scholar
• Fávero FM, Voos MC, Castro I. d, Caromano FA, Oliveira ASB. Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS. Arq Neuropsiquiatr. 2017;75:515–22.
   PubMed Web of Science ®Google Scholar
• Valenzuela D, Zitko P, Lillo P. Amyotrophic lateral sclerosis mortality rates in Chile: a population based study (1994–2010). Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:372–7.
   PubMed Web of Science ®Google Scholar
• Valle J, Roberts E, Paulukonis S, Collins N, English P, Kaye W. Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:209–15.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, EURALS, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Larson TC, Kaye W, Mehta P, Horton DK. Amyotrophic lateral sclerosis mortality in the United States, 2011–2014. Neuroepidemiology 2018;51:96–103.
   PubMed Web of Science ®Google Scholar
• Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology 2008;71:1889–95.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2018;17:1083–97.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Marin B, Piccininni M, Arcuti S, Chiò A, Hardiman O, for EURALS, et al. Referral bias in ALS epidemiological studies. PLOS One. 2018;13:e0195821.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio' A, Couratier P, Mitchell JD, EURALS, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
   PubMed Web of Science ®Google Scholar
• Baldin E, Preux P-M, Couratier P, Pugliatti M, Marin B, FRALIM CONSORTIUM. Validity of death certificates in the identification of cases of amyotrophic lateral sclerosis (ALS) in the Limousin region, France. A population-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:1–7.
   Google Scholar
• Marin B, Couratier P, Preux P-M, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology 2011;36:29–38.
   PubMed Web of Science ®Google Scholar
• Bryc K, Velez C, Karafet T, Moreno-Estrada A, Reynolds A, Auton A, et al. Genome-wide patterns of population structure and admixture among Hispanic/Latino populations. PNAS 2010;107:8954–61.
   PubMed Web of Science ®Google Scholar
• Beleza-Meireles A, Al-Chalabi A. Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives. Amyotroph Lateral Scler. 2009;10:1–14.
   PubMed Web of Science ®Google Scholar
• Noonan CW, White MC, Thurman D, Wong L-Y. Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology 2005;64:1215–21.
   PubMed Web of Science ®Google Scholar
• Rechtman L, Jordan H, Wagner L, Horton DK, Kaye W. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:65–71.
   PubMed Web of Science ®Google Scholar
• Henning F, Heckmann JM, Naidu K, Vlok L, Cross HM, Marin B. The incidence of motor neuron disease/amyotrophic lateral sclerosis in South Africa: a 4-year prospective study. Eur J Neurol. 2021;28:81–9.
   PubMed Web of Science ®Google Scholar
• Roberts AL, Johnson NJ, Chen JT, Cudkowicz ME, Weisskopf MG. Race/ethnicity, socioeconomic status, and ALS mortality in the United States. Neurology 2016;87:2300–8.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: The origin of geographic difference. Neuroepidemiology 2019;52:93–103.
   PubMed Web of Science ®Google Scholar
• Rooney JPK, Brayne C, Tobin K, Logroscino G, Glymour MM, Hardiman O. Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease. Neurology 2017;88:2321–9.
   PubMed Web of Science ®Google Scholar
• Zou Z-Y, Zhou Z-R, Che C-H, Liu C-Y, He R-L, Huang H-P. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540–9.
   PubMed Web of Science ®Google Scholar
• World Bank. Life expectancy at birth, total (years) - Latin America & Caribbean | Data [Internet]. [cited 2021 Jan 7]. Available from: https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=ZJ
   Google Scholar
• Chiò A, Bottacchi E, Buffa C, Mutani R, Mora G, PARALS. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77:948–50.
   PubMed Web of Science ®Google Scholar
• Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:623–7.
   PubMed Web of Science ®Google Scholar
• Arthur KC, Calvo A, Price TR, Geiger JT, Chiò A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Atlas: country resources for neurological disorders. 2nd ed. Geneva: World Health Organization; 2017.
   Google Scholar
• Frenk J, Gómez-Dantés O. Health systems in Latin America: the search for universal health coverage. Arch Med Res. 2018;49:79–83.
   PubMed Web of Science ®Google Scholar
• Bucheli ME, Calderón A, Chicaiza D, Franco C, López R, Digga E, et al. Feedback interaction of research, advocacy, and clinical care applied to ALS research in South America. Neurology. 2013;81:1959–61.
   PubMed Web of Science ®Google Scholar